Sparrow Hospital is a 733-bed teaching hospital located in Lansing, Michigan that provides care for the greater Mid-Michigan region. The hospital is a subsidiary of Sparrow Health System, and is affiliated with the Colleges of Human Medicine and Osteopathic Medicine at nearby Michigan State University.

There are 845 beds in Sparrow Clinical Research Institute.

During the past decade, Sparrow Clinical Research Institute conducted 45 clinical trials. In the 10-year time frame, 45 clinical trials started and 15 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 12 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Sparrow Clinical Research Institute" #1 sponsor was "Abbott Medical Devices" with 13 trials, followed by "Actelion" with 4 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 4 trials sponsored, "Medtronic" with 3 trials sponsored and "Amgen" with 3 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 29 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Sparrow Clinical Research Institute" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "Chiltern International Inc." with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Sparrow Clinical Research Institute" are "Heart Failure" (6 trials), "Stroke" (5 trials), "Atrial Fibrillation" (4 trials), "Bradycardia" (3 trials) and "Prader-Willi Syndrome" (3 trials). Many other conditions were trialed in "Sparrow Clinical Research Institute" in a lesser frequency.

Most popular intervention types in "Sparrow Clinical Research Institute" are "Device" (29 trials), "Drug" (17 trials), "Other" (10 trials), "Procedure" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "Apixaban" (2 trials), "DCCR" (2 trials), "Placebo for DCCR" (2 trials) and "Tesomet" (2 trials). Other intervention names were less common.

The vast majority of trials in "Sparrow Clinical Research Institute" are 53 trials for "All" genders.

Currently, there are NaN active trials in "Sparrow Clinical Research Institute". undefined are not yet recruiting, 11 are recruiting, 13 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 19 completed trials in Sparrow Clinical Research Institute, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Sparrow Clinical Research Institute, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 20 trials that are defined as “Not Applicable".